This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Virginia Commonwealth University, United States of America, as Represented by the Secretary of Agriculture, Other. Active years: 2003-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Richmond, VA (US) (2003 - 2005)
- Bon Air, VA (US) (2017 - 2021)
Company Filing History:
3 out of 420 
1 out of 1,216 
2 out of 834,453 Years Active: 2003-2021
Title: Innovations in Hemostasis: The Contributions of Robert F Diegelmann
Introduction
Robert F Diegelmann is a notable inventor based in Richmond, VA (US), recognized for his significant contributions to the field of hemostasis. With a total of 5 patents, Diegelmann has focused on developing innovative solutions for promoting blood clotting in hemorrhaging wounds. His work has the potential to greatly impact medical practices and improve patient outcomes in emergency situations.
Latest Patents
Diegelmann's latest patents include groundbreaking compositions that utilize clay minerals to facilitate hemostasis. One of his notable inventions is a method for hemostasis of wounds with high-pressure blood flow, which involves compositions comprising clay minerals such as bentonite. These compositions are designed to promote blood clotting when applied to a hemorrhaging wound. Additionally, he has developed electrospun or electrosprayed materials, such as bandages and micron beads, that incorporate clay minerals for the treatment of acute hemorrhage. Another significant patent focuses on hemostasis using kaolin and bentonite, further emphasizing the effectiveness of clay minerals in enhancing blood clotting.
Career Highlights
Throughout his career, Robert F Diegelmann has worked with Virginia Commonwealth University, where he has contributed to research and development in the field of hemostasis. His innovative approaches and dedication to improving medical treatments have established him as a respected figure in his field.
Collaborations
Diegelmann has collaborated with notable colleagues, including Dorne R Yager and Kevin R Ward, who have contributed to his research endeavors and innovations.
Conclusion
Robert F Diegelmann's work in the field of hemostasis showcases his commitment to advancing medical technology and improving patient care. His innovative patents and collaborations highlight the importance of research in developing effective solutions for critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile